Pulmonary hypertension and elevated transpulmonary gradient in patients with mitral stenosis

Journal of Heart Valve Disease

Volumn 19, Issue 6, 2010, Pages 708-715

  Hart, Stephen A ^a,b   Krasuski, Richard A ^b   Wang, Andrew ^c   Kisslo, Katherine ^c   Harrison, J Kevin ^c   Bashore, Thomas M ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL EFFECTIVENESS; CONVALESCENCE; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART LEFT ATRIUM PRESSURE; HEART RIGHT ATRIUM PRESSURE; HUMAN; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MITRAL VALVE AREA; MITRAL VALVE COMMISSUROTOMY; MITRAL VALVE GRADIENT; MITRAL VALVE STENOSIS; PERCUTANEOUS BALLOON MITRAL VALVE COMMISSUROTOMY; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RESTENOSIS; SEX DIFFERENCE; TRANSTHORACIC ECHOCARDIOGRAPHY; TRANSTHORACIC GRADIENT;

ADULT; AGED; BALLOON DILATION; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; NORTH CAROLINA; PROSPECTIVE STUDIES; PULMONARY ARTERY; PULMONARY CIRCULATION; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79551541293     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Dev V, Shrivastava S. Time course of changes in pulmonary vascular resistance and the mechanism of regression of pulmonary arterial hypertension after balloon mitral valvuloplasty. Am J Cardiol 1991;67:439-442
2. Fawzy ME, Hassan W, Stefadouros M, Moursi M, El Shaer F, Chaudhary MA. Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing mitral balloon valvotomy. J Heart Valve Dis 2004;13:942-947; discussion 947-948
3. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425-1436
4. Wood P, Besterman EM, Towers MK, McIlroy MB. The effect of acetylcholine on pulmonary vascular resistance and left atrial pressure in mitral stenosis. Br Heart J 1957;19:279-286
5. Gaine S. Pulmonary hypertension. JAMA 2000;284:3160-3168
6. Ward C, Hancock BW. Extreme pulmonary hypertension caused by mitral valve disease. Natural history and results of surgery. Br Heart J 1975;37:74-78
7. Vincens JJ, Temizer D, Post JR, Edmunds LH, Jr., Herrmann HC. Long-term outcome of cardiac surgery in patients with mitral stenosis and severe pulmonary hypertension. Circulation 1995;92:II137-42
8. Camara ML, Aris A, Padro JM, Caralps JM. Long-term results of mitral valve surgery in patients with severe pulmonary hypertension. Ann Thorac Surg 1988;45:133-136 (Pubitemid 18056439)
9. Lefevre T, Bonan R, Serra A, et al. Percutaneous mitral valvuloplasty in surgical high risk patients. J Am Coll Cardiol 1991;17:348-354
10. Reyes VP, Raju BS, Wynne J, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med 1994;331:961-967
11. American College of Cardiology/American Heart Association Task Force on Practice - Guidelines, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Bonow RO, Carabello BA, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-e231
12. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: An analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 1988;60:299-308
13. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75:175-183
14. Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 1984;87:394-402
15. Feldman T, Herrmann HC, Inoue K. Technique of percutaneous transvenous mitral commissurotomy using the Inoue balloon catheter. Cathet Cardiovasc Diagn 1994;Suppl.2:26-34 (Pubitemid 24276429)
16. Hatle L, Angelsen B, Tromsdal A. Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound. Circulation 1979;60:1096-1104
17. Costard-Jackle A, Hill I, Schroeder JS, Fowler MB. The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation 1991;84:III329-III337
18. Murali S, Kormos RL, Uretsky BF, et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: The Pittsburgh experience. Am Heart J 1993;126:896-904
19. Wang A, Krasuski RA, Warner JJ, et al. Serial echocardiographic evaluation of restenosis after successful percutaneous mitral commissurotomy. J Am Coll Cardiol 2002;39:328-334
20. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-S54
21. Fawzy ME, Mimish L, Sivanandam V, et al. Immediate and long-term effect of mitral balloon valvotomy on severe pulmonary hypertension in patients with mitral stenosis. Am Heart J 1996;131:89-93 (Pubitemid 26021369)
22. Krasuski RA, Warner JJ, Wang A, Harrison JK, Tapson VF, Bashore TM. Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology. J Am Coll Cardiol 2000;36:2204-2211
23. Sinha N, Kapoor A, Kumar AS, et al. Immediate and follow up results of Inoue balloon mitral valvotomy in juvenile rheumatic mitral stenosis. J Heart Valve Dis 1997;6:599-603 (Pubitemid 27524034)
24. Reid CL, Otto CM, Davis KB, Labovitz A, Kisslo KB, McKay CR. Influence of mitral valve morphology on mitral balloon commissurotomy: Immediate and six-month results from the NHLBI Balloon Valvuloplasty Registry. Am Heart J 1992;124:657-665
25. Fawzy ME, Shoukri M, Hassan W, Nambiar V, Stefadouros M, Canver CC. The impact of mitral valve morphology on the long-term outcome of mitral balloon valvuloplasty. Catheter Cardiovasc Intervent 2007;69:40-46
26. Umesan CV, Kapoor A, Sinha N, Kumar AS, Goel PK. Effect of Inoue balloon mitral valvotomy on severe pulmonary arterial hypertension in 315 patients with rheumatic mitral stenosis: Immediate and long-term results. J Heart Valve Dis 2000;9:609-615
27. Maoqin S, Guoxiang H, Zhiyuan S, et al. The clinical and hemodynamic results of mitral balloon valvuloplasty for patients with mitral stenosis complicated by severe pulmonary hypertension. Eur J Intern Med 2005;16:413-418
28. Ben Farhat M, Ayari M, Maatouk F, et al. Percutaneous balloon versus surgical closed and open mitral commissurotomy: Seven-year follow-up results of a randomized trial. Circulation 1998;97:245-250
29. Alfonso F, Macaya C, Hernandez R, et al. Percutaneous mitral valvuloplasty with severe pulmonary artery hypertension. Am J Cardiol 1993;72:325-330
30. Bahl VK, Chandra S, Talwar KK, Kaul U, Sharma S, Wasir HS. Balloon mitral valvotomy in patients with systemic and suprasystemic pulmonary artery pressures. Cathet Cardiovasc Diagn 1995;36:211-215
31. Fawzy ME, Osman A, Nambiar V, et al. Immediate and long-term results of mitral balloon valvuloplasty in patients with severe pulmonary hypertension. J Heart Valve Dis 2008;17:485-491
32. Manga P, Singh S, Brandis S, Friedman B. Mitral valve area calculations immediately after percutaneous balloon mitral valvuloplasty: Effect of the atrial septal defect. J Am Coll Cardiol 1993;21:1568-1573
33. Pitsavos CE, Stefanadis CI, Stratos CG, et al. Assessment of accuracy of the Doppler pressure half-time method in the estimation of the mitral valve area immediately after balloon mitral valvuloplasty. Eur Heart J 1997;18:455-463
34. Petrossian GA, Tuzcu EM, Ziskind AA, Block PC, Palacios I. Atrial septal occlusion improves the accuracy of mitral valve area determination following percutaneous mitral balloon valvotomy. Cathet Cardiovasc Diagn 1991;22:21-24
35. Levine MJ, Weinstein JS, Diver DJ, et al. Progressive improvement in pulmonary vascular resistance after percutaneous mitral valvuloplasty. Circulation 1989;79:1061-1067